1. Home
  2. LEGN vs WCC Comparison

LEGN vs WCC Comparison

Compare LEGN & WCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • WCC
  • Stock Information
  • Founded
  • LEGN 2014
  • WCC 1922
  • Country
  • LEGN United States
  • WCC United States
  • Employees
  • LEGN N/A
  • WCC N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • WCC Telecommunications Equipment
  • Sector
  • LEGN Health Care
  • WCC Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • WCC Nasdaq
  • Market Cap
  • LEGN 7.0B
  • WCC 8.0B
  • IPO Year
  • LEGN 2020
  • WCC 1999
  • Fundamental
  • Price
  • LEGN $27.69
  • WCC $171.23
  • Analyst Decision
  • LEGN Strong Buy
  • WCC Buy
  • Analyst Count
  • LEGN 13
  • WCC 7
  • Target Price
  • LEGN $75.67
  • WCC $216.57
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • WCC 764.8K
  • Earning Date
  • LEGN 05-13-2025
  • WCC 05-01-2025
  • Dividend Yield
  • LEGN N/A
  • WCC 1.05%
  • EPS Growth
  • LEGN N/A
  • WCC 10.34
  • EPS
  • LEGN N/A
  • WCC 13.26
  • Revenue
  • LEGN $728,303,000.00
  • WCC $21,812,500,000.00
  • Revenue This Year
  • LEGN $65.96
  • WCC $3.99
  • Revenue Next Year
  • LEGN $52.55
  • WCC $4.19
  • P/E Ratio
  • LEGN N/A
  • WCC $13.01
  • Revenue Growth
  • LEGN 112.46
  • WCC N/A
  • 52 Week Low
  • LEGN $29.27
  • WCC $125.21
  • 52 Week High
  • LEGN $60.87
  • WCC $216.17
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 29.04
  • WCC 59.73
  • Support Level
  • LEGN $30.25
  • WCC $156.35
  • Resistance Level
  • LEGN $33.30
  • WCC $176.54
  • Average True Range (ATR)
  • LEGN 1.78
  • WCC 4.94
  • MACD
  • LEGN -0.53
  • WCC 1.81
  • Stochastic Oscillator
  • LEGN 3.10
  • WCC 78.84

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About WCC WESCO International Inc.

Wesco International is an industrial distributor that has three reportable segments, electrical and electronic solutions, communications and security solutions, and utility and broadband solutions. The company offers more than 1.5 million products to its 140,000 active customers through a distribution network of 800 branches, warehouses, and sales offices, including 43 distribution centers. Wesco generates approximately 74% of its sales in the United States, but it has a global reach, with operations in 50 other countries.

Share on Social Networks: